The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas

Oncogene

Volumn 33, Issue 27, 2014, Pages 3506-3518

  Leufke, C ^a   Leykauf, J ^a   Krunic, D ^a   Jauch, A ^b   Holtgreve Grez, H ^a,b   Bohm Steuer B ^b   Brocker E B ^c   Mauch, C ^d   Utikal, J ^b   Hartschuh, W ^b   Purdie, K J ^e   Boukamp, P ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

actinic keratosis; non melanoma skin cancer; telomere length; telomere organization

Indexed keywords

CYCLIN D1; PROTEIN P53; TELOMERASE;

ARTICLE; BASAL CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; ENZYME ACTIVITY; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; TELOMERE; TELOMERE HOMEOSTASIS; TUMOR GROWTH; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHILD; CYCLIN D1; DISEASE PROGRESSION; GENOMIC INSTABILITY; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; TELOMERASE; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84903897205     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.323     Document Type: Article

References (44)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
2. de Fijter JW. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation. Nephrol Dial Transplant 2007; 22(Suppl 1): i23-i26.
3. Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363: 809-819.
4. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005; 26: 1657-1667.
5. Burnworth B, Arendt S, Muffler S, Steinkraus V, Brocker EB, Birek C et al. The multistep process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Eur J Cell Biol 2007; 86: 763-780.
6. Pacifico A, Goldberg LH, Peris K, Chimenti S, Leone G, Ananthaswamy HN. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. Br J Dermatol 2008; 158: 291-297.
7. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G et al. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Cancer Lett 2008; 264: 145-161.
8. Burnworth B, Popp S, Stark HJ, Steinkraus V, Brocker EB, Hartschuh W et al. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 2006; 25: 4399-4412.
9. Utikal J, Udart M, Leiter U, Kaskel P, Peter RU, Krahn G. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer. Cancer Lett 2005; 219: 197-204.
10. Toll A, Salgado R, Yebenes M, Martin-Ezquerra G, Gilaberte M, Baro T et al. MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol 2009; 161: 1112-1118.
11. Jin Y, Martins C, Jin C, Salemark L, Jonsson N, Persson B et al. Nonrandom kar-yotypic features in squamous cell carcinomas of the skin. Genes Chromosomes Cancer 1999; 26: 295-303.
12. Popp S, Waltering S, Herbst C, Moll I, Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002; 99: 352-360.
13. Purdie KJ, Lambert SR, Teh MT, Chaplin T, Molloy G, Raghavan M et al. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer 2007; 46: 661-669.
14. Purdie KJ, Harwood CA, Gulati A, Chaplin T, Lambert SR, Cerio R et al. Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs. J Invest Dermatol 2009; 129: 1562-1568.
15. Salgado R, Toll A, Espinet B, Gonzalez-Roca E, Barranco CL, Serrano S et al. Analysis of cytogenetic abnormalities in squamous cell carcinoma by array comparative genomic hybridization. Acta Dermosifiliogr 2008; 99: 199-206.
16. Dworkin AM, Ridd K, Bautista D, Allain DC, Iwenofu OH, Roy R et al. Germline variation controls the architecture of somatic alterations in tumors. PLoS Genet 2010; 6: e1001136.
17. Desmaze C, Soria JC, Freulet-Marriere MA, Mathieu N, Sabatier L. Telomere-driven genomic instability in cancer cells. Cancer Lett 2003; 194: 173-182.
18. Lansdorp PM. Telomeres and disease. EMBO J 2009; 28: 2532-2540.
19. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-776.
20. Ermler S, Krunic D, Knoch TA, Moshir S, Mai S, Greulich-Bode KM et al. Cell cycle-dependent 3D distribution of telomeres and telomere repeat-binding factor 2 (TRF2) in HaCaT and HaCaT-myc cells. Eur J Cell Biol 2004; 83: 681-690.
21. Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B et al. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2004; 2: 12.
22. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z et al. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 2005; 102: 9613-9618.
23. Murnane JP. Telomere dysfunction and chromosome instability. Mutat Res 2012; 730: 28-36.
24. Krunic D, Moshir S, Greulich-Bode KM, Figueroa R, Cerezo A, Stammer H et al. Tissue context-activated telomerase in human epidermis correlates with little age-dependent telomere loss. Biochim Biophys Acta 2009; 1792: 297-308.
25. Perrem K, Lynch A, Al NF, Leader M, Elaine K. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population. Hum Pathol 2008; 39: 1034-1041.
26. Shay JW, Wright WE. Ageing and cancer: the telomere and telomerase connection. Novartis Found Symp 2001; 235: 116-125.
27. Bachor C, Bachor OA, Boukamp P. Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. J Cancer Res Clin Oncol 1999; 125: 453-460.
28. Perrem K, Lynch A, Conneely M, Wahlberg H, Murphy G, Leader M et al. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths. Hum Pathol 2007; 38: 351-358.
29. Fabricius EM, Kruse-Boitschenko U, Khoury R, Wildner GP, Raguse JD, Klein M et al. Localization of telomerase hTERT protein in frozen sections of basal cell carcinomas (BCC) and tumor margin tissues. Int J Oncol 2009; 35: 1377-1394.
30. Ren ZP, Ahmadian A, Ponten F, Nister M, Berg C, Lundeberg J et al. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Pathol 1997; 150: 1791-1803.
31. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
32. Jones MJ, Jallepalli PV. Chromothripsis: chromosomes in crisis. Dev Cell 2012; 23: 908-917.
33. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771.
34. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 1993; 14: 833-839.
35. Cerezo A, Kalthoff H, Schuermann M, Schafer B, Boukamp P. Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 2002; 115: 1305-1312.
36. Geigl JB, Uhrig S, Speicher MR. Multiplex-fluorescence in situ hybridization for chromosome karyotyping. Nat Protoc 2006; 1: 1172-1184.
37. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet 2012; 13: 693-704.
38. Xu L, Li S, Stohr BA. The role of telomere biology in cancer. Annu Rev Pathol 2012; 8: 49-78.
39. Zimmer C, Fabre E. Principles of chromosomal organization: lessons from yeast. J Cell Biol 2011; 192: 723-733.
40. Raz V, Vermolen BJ, Garini Y, Onderwater JJ, Mommaas-Kienhuis MA, Koster AJ et al. The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells. J Cell Sci 2008; 121: 4018-4028.
41. Balasubramanian S, Hurley LH, Neidle S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov 2011; 10: 261-275.
42. du Manoir S, Speicher MR, Joos S, Schrock E, Popp S, Dohner H et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993; 90: 590-610.
43. Boukamp P, Popp S, Altmeyer S, Hulsen A, Fasching C, Cremer T et al. Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes Chromosomes Cancer 1997; 19: 201-214.
44. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin kera-tinocytes. Proc Natl Acad Sci USA 1996; 93: 6476-6481.